| Identification | More | [Name]
5-HYDROXY-L-TRYPTOPHAN | [CAS]
314062-44-7 | [Synonyms]
2-AMINO-3-(5-HYDROXY-1H-INDOL-3-YL)PROPIONIC ACID
5-HTP
5-HYDROXY-L-TRP-OH
(-)-5-HYDROXY-L-TRYPTOPHAN
5-HYDROXY-L-TRYPTOPHAN
5-HYDROXY-TRP-OH
5-HYDROXYTRYPTOPHAN
C5-HYDROXY-L-TRYPTOPHAN
H-5-HYDROXY-TRP-OH
H-TRP(5-OH)-OH
L-2-AMINO-3-(5-HYDROXYINDOLYL)PROPIONIC ACID
L-5-HTP
L-5-HYDROXYTRYPTOPHAN
L-5-HYDROXYTRYPTOPHAN HYDRATE
OXITRIPTAN
(S)-2-AMINO-3-(5-HYDROXY-1H-INDOL-3-YL)-PROPIONIC ACID | [EINECS(EC#)]
224-411-1 | [Molecular Formula]
C11H12N2O3 | [MDL Number]
MFCD00064341 | [Molecular Weight]
220.22 | [MOL File]
314062-44-7.mol |
| Chemical Properties | Back Directory | [Melting point ]
270 °C (dec.)(lit.) | [density ]
0.902 g/mL at 25 °C(lit.)
| [refractive index ]
n20/D 1.4850(lit.)
| [Fp ]
175 °F
| [storage temp. ]
2-8°C
| [solubility ]
H2O: 10 mg/mL
| [form ]
solid
| [color ]
white
| [InChI]
InChI=1/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/s3 | [InChIKey]
LDCYZAJDBXYCGN-DJEYLCQNNA-N | [SMILES]
C12C=C(C=CC=1NC=C2C[C@H](N)C(=O)O)O |&1:10,r| | [CAS DataBase Reference]
314062-44-7(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xn | [Risk Statements ]
R22:Harmful if swallowed. | [Safety Statements ]
S36:Wear suitable protective clothing . | [RIDADR ]
UN 2811 6.1/PG 3
| [WGK Germany ]
3
| [RTECS ]
YN7110000
| [F ]
3-10 |
| Hazard Information | Back Directory | [Description]
5-hydroxy-l-tryptophan (5-HTP) is a chemical byproduct of the protein building block L-tryptophan. It is produced commercially from the seeds of an African plant known as Griffonia simplicifolia. In vivo, it is produced from tryptophan by tryptophan hydroxylase (TPH), and its decarboxylation yields serotonin (5-hydroxytryptamine, 5-HT), a monoamine neurotransmitter involved in the modulation of mood, cognition, reward, learning, memory, sleep, and numerous other physiological processes. 5-HTP is both a drug and a natural component of some dietary supplements, and occurrence in both synthetic tryptophan and 5-HTP of toxic impurities has caused eosinophilia myalgia syndrome cases[1]. | [History]
5-hydroxy-l-tryptophan (5-HTP) has been used clinically for more than 30 yr. Sales and awareness of 5-HTP increased in 1989 after the Food and Drug Administration (FDA) banned its precursor, L-tryptophan, because of its association with eosinophilia-myalgia syndrome. Since then, 5-HTP has been marketed as a safe alternative to L-tryptophan.
| [Uses]
5-hydroxy-l-tryptophan is metabolized into serotonin and is thought to alleviate depression by enhancing serotonin neurotransmission. It is also used to treat fibromyalgia, insomnia, binge-eating, attention deficit disorder, and chronic headaches. | [Side effects]
Administration of 5-hydroxy-l-tryptophan in patients with major depression who received selective serotonin reuptake inhibitors like fluoxetine resulted in significantly increased levels of cortisol and prolactin in plasma compared with untreated depressed patients, suggesting that the adverse effect of 5-hydroxy-l-tryptophan was potentiated by fluoxetine. The main side effects of 5-hydroxy-l-tryptophan are dose-related, and sleepiness, fatigue, nausea, or vomiting are the most cited. | [Metabolism]
5-Hydroxy-l-tryptophan is a precursor for melatonin (N-acetyl-5-methoxytryptamine, a regulatory hormone of circadian rhythm) that is synthesized from serotonin via N-acetyl-serotonin. It is transported to various body tissues, including the brain, where it is transformed into serotonin. The absorption of 5-hydroxy-tryptophan and its decarboxylation to serotonin are processes of variable efficiencies (47%–84%). The serotonin is metabolized sequentially to its inactive metabolites, and it is excreted in the form of 5-hydroxyindoleacetic acid.
| [References]
[1] Maffei, Massimo E. "5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology." International Journal of Molecular Sciences 22.1(2021):181. |
|
|